Mesfin Tegenu, MS, RPh

CEO and Chairman at RxParadigm

Speaker

Mesfin Tegenu is a nationally recognized thought leader in the Pharmacy Benefit Management industry, an early pioneer who built one of the nation’s top transparent Pharmacy benefit Organization.

Since his early career as a clinical pharmacist, Mesfin has focused on innovative approaches that improve patient outcomes and reduce total care costs. His patient-centered vision often placed him at odds with the industry's trend toward reduced transparency and patient focus.

These challenges led Mesfin to establish RxParadigm, Inc. (www.rxparadigm.com), a groundbreaking venture focused on restoring transparency and patient-centered solutions to the pharmaceutical supply chain. RxParadigm introduces disruptive strategies, including its flagship innovation, Tungsten+ PLUS—a platform with unique capabilities that streamline 340B program administration. It establishes the nation’s first neutral, collaborative, and market-driven 340B drug clearinghouse, designed to resolve an estimated $20 to $30 billion (WAC) in duplicate payments. These inefficiencies stem from the lack of transparency and absence of a neutral system among covered entities, health plans, payers, government-funded programs, and pharmaceutical companies for certifying 340B claims.

Mesfin is actively engaged in community and industry organizations. He serves on the board of EPPAD (Ethiopian Pharmacy and Pharmaceutical Scientists Association) and is the founder and executive chairman of the American Ethiopian Public Affairs Committee (AEPAC). He is also a member of the Academy of Managed Care Pharmacy (AMCP).

A frequent speaker, Mesfin is regularly cited by leading trade journals for his insights on drug access, pricing, and management.